Apple has escalated its legal attack on Qualcomm, declaring the iPhone broadband chip license agreement is invalid, and the manufacturer is illegally double-dipping in its demand for a royalty payment for chip technology in conjunction with charging for the chips.
First reported by Reuters, Apple is utilizing a recent US Supreme Court decision that put tighter restrictions on manufacturers to control how products are used or resold. Apple argues that Qualcomm is entitled to only “one reward” rather than reaping profit on the sale of the chip, and charging a percentage of the iPhone selling price from the intellectual property license.
The formal buyers of the broadband chips are Apple’s manufacturers —which then pass the costs on to Apple. As part of the filing, Apple has asked the court to stop Qualcomm’s lawsuits against Foxconn, and three other manufacturers.
The lawsuit that started the battle was filed in January, with Apple accusing Qualcomm of unfair licensing terms. Apple claims that Qualcomm withheld nearly US$1 billion in rebates in retaliation for participating in a South Korean antitrust investigation.
Apple alleges Qualcomm abuses its “monopoly power” of the mobile wireless chip market to skirt fair, reasonable and nondiscriminatory (FRAND) commitments to charge customers exorbitant royalty rates for standard essential patent (“SEP”). Qualcomm also restricts sales of chips to buyers who have agreed to license its SEPs, a practice Apple refers to as “double-dipping” —the point hammered home in the court filing on Monday.
Those accusations mirror certain claims addressed in a US Federal Trade Commission antitrust lawsuit also lodged in January.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas